What does Maureen Masset Ophtalmologie do?

Maureen Masset Ophtalmologie is a specialist medical practice in Tubize. Private Limited, started on 16 September 2020, 1 establishment.

What is the address of Maureen Masset Ophtalmologie?

The registered office of Maureen Masset Ophtalmologie is located at Rue du Gros Chêne 123, 1480 Tubize.

Is Maureen Masset Ophtalmologie still active?

Yes. According to the CBE (17 September 2026) Maureen Masset Ophtalmologie is active, legal situation “Normale toestand”, started on 16 September 2020.

Is Maureen Masset Ophtalmologie registered on Peppol?

Yes, Maureen Masset Ophtalmologie is registered on the Peppol network with ID 0208:0754481143.

What is the enterprise number of Maureen Masset Ophtalmologie?

The enterprise number of Maureen Masset Ophtalmologie is BE0754481143.

When was Maureen Masset Ophtalmologie founded?

Maureen Masset Ophtalmologie was founded on 16 September 2020.

Who are the directors of Maureen Masset Ophtalmologie?

According to the 2025 annual accounts, the directors of Maureen Masset Ophtalmologie are: Maurren MASSET.

Is Maureen Masset Ophtalmologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 September 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Maureen Masset Ophtalmologie make in 2025?

Maureen Masset Ophtalmologie posted a profit after taxes of € 113,616 in financial year 2025.

What is the revenue of Maureen Masset Ophtalmologie?

As a small company, Maureen Masset Ophtalmologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 146,967.

Maureen Masset Ophtalmologie (Private Limited) - Tubize

Dossier Maureen Masset Ophtalmologie, printed on 17 September 2026 from databakkes.be/en/0754481143/maureen-masset-ophtalmologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Maureen Masset Ophtalmologie from Tubize, company number BE0754481143, closed financial year 2025 with a result of € 113,616 after tax. For that financial year Maureen Masset Ophtalmologie recorded a gross margin of € 146,967 and equity of € 28,107. Compared with financial year 2024, the result moved from € 86,037 to € 113,616. Profitable, and profit is growing. The buffer shrank hard: equity is 79 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 19, 2026.

What it is worth Shrank hard

€ 28,107

▼ 79% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 113,616

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 221,508

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 222,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 455

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,352

▲ € 4,300 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 32,484

▲ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 74,434 Gross margin 2022: € 74,434 First fiscal year in the series	€ 140,452 Gross margin 2023: € 140,452 ▲ 89% vs 2022 (€ 74,434) Favourable step	€ 114,148 Gross margin 2024: € 114,148 ▼ 19% vs 2023 (€ 140,452) Unfavourable step	€ 146,967 Gross margin 2025: € 146,967 ▲ 29% vs 2024 (€ 114,148) Favourable step	▲ 29%
Profit after taxes	€ 56,321 Profit after taxes 2022: € 56,321 First fiscal year in the series	€ 112,308 Profit after taxes 2023: € 112,308 ▲ 99% vs 2022 (€ 56,321) Favourable step	€ 86,037 Profit after taxes 2024: € 86,037 ▼ 23% vs 2023 (€ 112,308) Unfavourable step	€ 113,616 Profit after taxes 2025: € 113,616 ▲ 32% vs 2024 (€ 86,037) Favourable step	▲ 32%
Equity	€ 108,146 Equity 2022: € 108,146 First fiscal year in the series	€ 220,455 Equity 2023: € 220,455 ▲ 104% vs 2022 (€ 108,146) Favourable step	€ 136,491 Equity 2024: € 136,491 ▼ 38% vs 2023 (€ 220,455) Unfavourable step	€ 28,107 Equity 2025: € 28,107 ▼ 79% vs 2024 (€ 136,491) Unfavourable step	▼ 79%
Total debts	€ 22,781 Total debts 2022: € 22,781 First fiscal year in the series	€ 34,511 Total debts 2023: € 34,511 ▲ 51% vs 2022 (€ 22,781) Unfavourable step	€ 196,344 Total debts 2024: € 196,344 ▲ € 161,833 vs 2023 (€ 34,511) Unfavourable step	€ 261,350 Total debts 2025: € 261,350 ▲ 33% vs 2024 (€ 196,344) Unfavourable step	▲ 33%
Cash	€ 69,082 Cash 2022: € 69,082 First fiscal year in the series	€ 162,891 Cash 2023: € 162,891 ▲ 136% vs 2022 (€ 69,082) Favourable step	€ 217,749 Cash 2024: € 217,749 ▲ 34% vs 2023 (€ 162,891) Favourable step	€ 221,508 Cash 2025: € 221,508 ▲ 2% vs 2024 (€ 217,749) Favourable step	▲ 2%
Retained profit	€ 93,146 Retained profit 2022: € 93,146 First fiscal year in the series	€ 205,455 Retained profit 2023: € 205,455 ▲ 121% vs 2022 (€ 93,146) Favourable step	€ 121,491 Retained profit 2024: € 121,491 ▼ 41% vs 2023 (€ 205,455) Unfavourable step	€ 13,107 Retained profit 2025: € 13,107 ▼ 89% vs 2024 (€ 121,491) Unfavourable step	▼ 89%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 170,000 Dividend 2024: € 170,000 Unchanged (€ 0) Unchanged	€ 222,000 Dividend 2025: € 222,000 ▲ 31% vs 2024 (€ 170,000) Unchanged	▲ 31%
Balance sheet total	€ 130,928 Balance sheet total 2022: € 130,928 First fiscal year in the series	€ 254,966 Balance sheet total 2023: € 254,966 ▲ 95% vs 2022 (€ 130,928) Unchanged	€ 332,835 Balance sheet total 2024: € 332,835 ▲ 31% vs 2023 (€ 254,966) Unchanged	€ 289,457 Balance sheet total 2025: € 289,457 ▼ 13% vs 2024 (€ 332,835) Unchanged	▼ 13%

Key figures of Maureen Masset Ophtalmologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Maureen Masset Ophtalmologie?

What happened at Maureen Masset Ophtalmologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 19, 2026 New annual accounts for financial year 2025: profit of € 113,616 (▲ 32% vs 2024). Source: NBB ↗
Sep 16, 2020 New establishment in Tubize. KBO
Sep 16, 2020 Start of the company according to the CBE. KBO

In short

From € 56,321 profit in 2022 to € 113,616 profit in 2025.

Paid € 101,556 in corporate taxes since 2022.

Best year ever: 2025, with € 113,616 profit.

Paid out € 392,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Maureen Masset Ophtalmologie? We notify you, reason included.

Follow Maureen Masset Ophtalmologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Maurren MASSET

Maureen Masset Ophtalmologie

Behind Maureen Masset Ophtalmologie is Maurren MASSET.

See the full network in the app

Directors

According to the 2025 annual accounts

Maurren MASSET

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Gros Chêne 123

1480 Tubize

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0754.481.143
VAT number: BE 0754.481.143
Registered office: Rue du Gros Chêne 123, 1480 Tubize
Names & denominations: Maureen Masset Ophtalmologie · MM Ophta
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 September 2020
Peppol: Active · Active since 18 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗